Back to Index

MUKTAARTS Daily Market Report

Date Range: 2016-01-01 to 2026-10-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Current Snapshot — MUKTAARTS Report
Metric Value
Latest closed session 2026-10-26
Latest close 45.4400
20-session average turnover 184540.66
Distance from 252-session high -35.42%

Trailing Price Returns

Trailing Price Returns — MUKTAARTS Report
Sessions Return
1 -4.03%
5 -17.84%
20 -20.84%
60 -24.24%
120 -22.46%
250 -34.26%

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Current Market Intelligence Candidates — MUKTAARTS Report
Archetype Regime Primary horizon Strength First rejection risk
MEAN_REVERSION_CAPITULATION BEAR_PERSISTENT 20 2.97 Continued trend momentum breakdown
PRICE_DISLOCATION BEAR_PERSISTENT 120 0.24 Continued price deterioration or adverse fundamental evidence

Evidence Limits

Fundamental Research

Fundamental Research — MUKTAARTS Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth 4.31%
Net margin -6.79%
Return on equity 19.03%
Debt/equity -1.22
Operating cash flow/net income -0.59
Free-cash-flow margin 1.59%
Trailing P/E 20.81
Price/book N/A

Source: EODHD retrieved 2026-09-23T14:00:31.797485+00:00.

QA flags: balance_sheet_equation: difference=73770000.00; weak_cash_conversion: operating cash flow/net income below 0.5

Missing statements mean data is unavailable. Balance-sheet equation flags require checking accounting definitions and units. Weak cash conversion and high leverage are financial risk observations, not necessarily data errors. A summary-only record cannot establish financial quality.

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.